SUMO2 pseudogene 8 (SUMO2P8)

SUMO2 pseudogene 8 (SUMO2P8) is one of several pseudogenes derived from the SUMO2 gene, part of the small ubiquitin-like modifier protein family involved in post-translational modification (SUMOylation)[2][3][5]. Pseudogenes are DNA sequences similar to known genes but lack the ability to produce a functional protein due to sequence degradation or other mutations[4][5]. While the parent protein (SUMO2) is essential for many cellular processes, including transcription regulation, DNA repair, and stress responses[1][3][7], pseudogenes such as SUMO2P8 do not participate directly in these functions. The scientific literature does not support SUMO2P8 as a true pharmacological, therapeutic, or diagnostic target. SUMO2P8 (SUMO2 pseudogene 8) is a genomically annotated pseudogene, not a valid molecular target for drug discovery or clinical development. If you need information about SUMO2 (small ubiquitin-like modifier 2), which is an active modifier protein involved in cell regulation, it should be considered instead[1][3][7][8].

Other names

SUMO2P8ENST00000504193